Trademark Overview
On Thursday, February 6, 2025, a trademark application was filed for NRQ with the United States Patent and Trademark Office. The USPTO has given the NRQ trademark a serial number of 99030897. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Thursday, February 6, 2025. This trademark is owned by MicroNeb Tech Holdings Inc.. The NRQ trademark is filed in the Pharmaceutical Products and Medical Instrument Products categories with the following description:
Pharmaceutical preparations, namely, opioid antagonists for use in the treatment of opioid overdose, partial opioid antagonists for the treatment of opioid use disorder; Sympathomimetic agents for the treatment of anaphylaxis and analgesics for the treatment of severe acute pain; Pulmonary drug delivery devices, atomizers and nebulizer devices for pulmonary delivery, and devices for pulmonary delivery all pre-filled with capsules having pharmaceuticals, namely, opioid antagonists and narcotic antagonists and pharmaceutical drug preparations
Nebulizers and atomizers for medical purposes; Nebulizer and atomizers for administering medication in the form of a mist inhaled into the lungs; Atomizers and nebulizers sold for medical use; Medical apparatus for introducing pharmaceutical preparations into the human body; Medical vials in the nature of atomizers sold empty for medical purposes; Medical vials in the nature of nebulizers for medical purposes
